CD44 in Bladder Cancer

Cancers (Basel). 2024 Mar 18;16(6):1195. doi: 10.3390/cancers16061195.

Abstract

The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer.

Keywords: CD44; androgen receptor; bladder cancer; glycosylation; hyaluronic acid.

Publication types

  • Review